Tango Therapeutics

TNGX57

$8.41arrow_drop_up1.57%$0.13

TNGX57

$8.41

arrow_drop_up1.57%$0.13

Performance History

Key Stats
Open	$8.51
Prev. Close	$8.28
EPS	-1.11
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	8.15	8.67
52 Week Range	5.15	13.03

Ratios







EPS	-1.11

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Tango Therapeutics (TNGX)

Tango Therapeutics, Inc. (TNGX) is a biotechnology company that specializes in the discovery and development of targeted cancer therapies. The company's focus is on utilizing a next-generation sequencing platform to identify and target genetic vulnerabilities in cancer cells. By targeting these vulnerabilities, Tango Therapeutics aims to develop more effective and personalized treatments for cancer patients.

One of the key features of Tango Therapeutics' approach is its use of smart analysis. By combining advanced computational algorithms with high-throughput sequencing data, the company is able to rapidly analyze large amounts of genomic data. This allows Tango Therapeutics to identify potential drug targets and develop therapies that have a higher likelihood of success. The company's smart analysis platform is constantly evolving and improving, ensuring that Tango Therapeutics stays at the forefront of cancer drug discovery.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Headquarters: Boston
Employees: 110
Exchange: NASDAQ

Keep an eye on Tango Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Tango Therapeutics's (TNGX) price per share?

The current price per share for Tango Therapeutics (TNGX) is $8.41. The stock has seen a price change of $0.13 recently, indicating a 1.57% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Tango Therapeutics (TNGX)?

For Tango Therapeutics (TNGX), the 52-week high is $13.03, which is 54.93% from the current price. The 52-week low is $5.15, the current price is 63.3% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Tango Therapeutics (TNGX) a growth stock?

Tango Therapeutics (TNGX) has shown an average price growth of 0.41% over the past three years. It has received a score of 77 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Tango Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Tango Therapeutics (TNGX) stock price performance year to date (YTD)?

As of the latest data, Tango Therapeutics (TNGX) has a year-to-date price change of -15.73%. Over the past month, the stock has experienced a price change of -21.25%. Over the last three months, the change has been -11.84%. Over the past six months, the figure is 0.24%.

help

Is Tango Therapeutics (TNGX) a profitable company?

Tango Therapeutics (TNGX) has a net income of -$101.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 93.39% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -148.69% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $36.53M, with a revenue growth rate of 46.93%, providing insight into the company's sales performance and growth. The gross profit is $34.11M. Operating income is noted at -$114.17M. Furthermore, the EBITDA is -$129.96M.

help

What is the market capitalization of Tango Therapeutics (TNGX)?

Tango Therapeutics (TNGX) has a market capitalization of $895.72M. The average daily trading volume is 1.7M, indicating the stock's liquidity and investor engagement.